This case report details the unfortunate journey of a 59-year-old breast cancer survivor who developed secondary Retroperitoneal Fibrosis (RPF) in 2022. Despite diligent treatment efforts, her condition took a devastating turn when, in June 2023, she was diagnosed not only with persistent RPF but also with advanced liver, omental, and duodenal cancer. Tragically, her condition deteriorated rapidly, leading to her passing on day 41 following her presentation. This case underscores the challenges of diagnosing and treating RPF. It highlights the importance of considering cancer development in advanced RPF cases that do not respond to treatment, often leaving limited options for effective intervention.
Retroperitoneal Fibrosis Liver Cancer Metastasis Steroid Azathioprine.
Necessary permissions were obtained from the first degree family.
We would like to thank the deceased A. S. and her precious family for their contributions to science.
Birincil Dil | İngilizce |
---|---|
Konular | Klinik Onkoloji, Klinik Tıp Bilimleri (Diğer) |
Bölüm | Case Report |
Yazarlar | |
Yayımlanma Tarihi | 29 Mart 2024 |
Gönderilme Tarihi | 14 Ocak 2024 |
Kabul Tarihi | 16 Ocak 2024 |
Yayımlandığı Sayı | Yıl 2024 Cilt: 15 Sayı: 1 |